451 – 500 of 549
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
The usefulness of a multidisciplinary educational programme after breast cancer surgery: A prospective and comparative study
(
- Contribution to journal › Article
-
Mark
Cyclin e overexpression reduces infiltrative growth in breast cancer - Yet another link between proliferation control and tumor invasion
(
- Contribution to journal › Article
- 2005
-
Mark
Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells
(
- Contribution to journal › Article
-
Mark
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
(
- Contribution to journal › Article
-
Mark
Inverse vs. forward breast IMRT planning
(
- Contribution to journal › Article
-
Mark
High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: Implications for breast and ovarian cancer risk.
(
- Contribution to journal › Article
-
Mark
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
(
- Contribution to journal › Article
-
Mark
Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
(
- Contribution to journal › Article
-
Mark
Estrogen receptor alpha and beta in breast cancer - gene expression profiles and clinical implications
2005)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cyclin E overexpression and associated events in human breast cancer
2005)(
- Thesis › Doctoral thesis (compilation)
-
Mark
High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells.
(
- Contribution to journal › Article
-
Mark
TISSUE MICROARRAY PERSPECTIVES ON CYCLIN D1 IN BREAST CANCER: Progression, prognosis and prediction
2005)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Functional and Molecular Characterization of BRCA1 and BRCA2 Associated Breast Cancer
2005)(
- Thesis › Doctoral thesis (compilation)
- 2004
-
Mark
Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? - A population-based study
(
- Contribution to journal › Article
-
Mark
Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation
(
- Contribution to journal › Article
-
Mark
Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables
(
- Contribution to journal › Article
-
Mark
Molecular Cytogenetics in Sporadic Breast Cancer
2004)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Apoptotic cell death in the lactating mammary gland is enhanced by a folding variant of alpha-lactalbumin
(
- Contribution to journal › Article
-
Mark
Tamoxifen response in primary breast cancer with special reference to tumour-specific VEGF-A and VEGFR2
2004)(
- Thesis › Doctoral thesis (compilation)
- 2003
-
Mark
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
C-erbB2, p27 and G1/S aberrations in human primary breast cancer
(
- Contribution to journal › Article
-
Mark
Phantom study of radiation doses outside the target volume brachytherapy versus external radiotherapy of early breast cancer
(
- Contribution to journal › Article
-
Mark
A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)
(
- Contribution to journal › Article
-
Mark
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of ductal carcinomas in situ and invasive breast tumors
(
- Contribution to journal › Article
-
Mark
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status
(
- Contribution to journal › Scientific review
-
Mark
An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole
(
- Contribution to journal › Article
-
Mark
Liposuction of arm lymphoedema.
(
- Contribution to journal › Article
-
Mark
Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines
(
- Contribution to journal › Article
-
Mark
Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer
(
- Contribution to journal › Article
-
Mark
Dietary fat as an exposure in epidemiological studies. Observations in the Malmö Diet and Cancer cohort
2003)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Breast cancer patients' experiences of lymphoedema
(
- Contribution to journal › Article
-
Mark
Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients
(
- Contribution to journal › Article
-
Mark
Role of Wnt-5a in breast cancer
2003)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Clinical Aspects of Hereditary Breast Cancer
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors
(
- Contribution to journal › Article
-
Mark
Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden
(
- Contribution to journal › Article
-
Mark
Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease
(
- Contribution to journal › Article
-
Mark
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node
(
- Contribution to journal › Article
-
Mark
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy
(
- Contribution to journal › Article
-
Mark
BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
(
- Contribution to journal › Article
-
Mark
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Lymphoedema and Breast Cancer. A Physiotherapeutic Approach.
2002)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Balancing - Cancer from a primary care perspective. Diagnosis, posttraumatic stress, and end-of-life care.
2002)(
- Thesis › Doctoral thesis (compilation)
- 2001
-
Mark
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
(
- Contribution to journal › Article